• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型半合成青霉素T-1220的体外及体内抗菌活性

In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

作者信息

Ueo K, Fukuoka Y, Hayashi T, Yasuda T, Taki H, Tai M, Watanabe Y, Saikawa I, Mitsuhashi S

出版信息

Antimicrob Agents Chemother. 1977 Oct;12(4):455-60. doi: 10.1128/AAC.12.4.455.

DOI:10.1128/AAC.12.4.455
PMID:921239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC429945/
Abstract

T-1220, sodium 6-[d-(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinylcarbonyl-amino)- alpha-phenylacetamido] penicillanate, is a new semisynthetic penicillin derivative that possesses a broad spectrum of in vitro antibacterial activity against gram-positive and gram-negative bacteria. T-1220 is more effective than carbenicillin (CB-PC) against Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus species, and Serratia marcescens. Addition of human serum to culture media did not significantly alter the antibacterial activity of T-1220. Greater bactericidal activity toward various strains of gram-negative bacteria was demonstrated with T-1220 than with CB-PC. T-1220, like penicillin G, was hydrolyzed by penicillinase, but was sable to a type IV penicillinase produced by P. aeruginosa strains. In vivo antibacterial activities of T-1220, ampicillin (AB-PC), and CB-PC were compared, using systemic infections of mice with P. aeruginosa, K. pneumoniae, and Escherichia coli. The 50% effective doses (milligrams per kilogram) of T-1220 were consistently lower than those of AB-PC and CB-PC.

摘要

T - 1220,即6 - [d - (-)-α-(4 - 乙基 - 2,3 - 二氧代 - 1 - 哌嗪基羰基 - 氨基)-α - 苯乙酰胺基]青霉烷酸钠,是一种新型半合成青霉素衍生物,对革兰氏阳性菌和革兰氏阴性菌具有广泛的体外抗菌活性。T - 1220对铜绿假单胞菌、肺炎克雷伯菌、变形杆菌属和粘质沙雷氏菌的抗菌活性比羧苄青霉素(CB - PC)更强。向培养基中添加人血清不会显著改变T - 1220的抗菌活性。与CB - PC相比,T - 1220对各种革兰氏阴性菌菌株表现出更强的杀菌活性。与青霉素G一样,T - 1220可被青霉素酶水解,但对铜绿假单胞菌菌株产生的IV型青霉素酶具有耐受性。利用小鼠全身性感染铜绿假单胞菌、肺炎克雷伯菌和大肠杆菌,比较了T - 1220、氨苄青霉素(AB - PC)和CB - PC的体内抗菌活性。T - 1220的50%有效剂量(毫克/千克)始终低于AB - PC和CB - PC。

相似文献

1
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.新型半合成青霉素T-1220的体外及体内抗菌活性
Antimicrob Agents Chemother. 1977 Oct;12(4):455-60. doi: 10.1128/AAC.12.4.455.
2
PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation.PC-904,一种新型的具有显著抗假单胞菌活性的广谱半合成青霉素:微生物学评价
Antimicrob Agents Chemother. 1976 Feb;9(2):262-73. doi: 10.1128/AAC.9.2.262.
3
PC-904, a new semisynthetic penicillin.PC - 904,一种新型半合成青霉素。
Antimicrob Agents Chemother. 1978 Jan;13(1):14-8. doi: 10.1128/AAC.13.1.14.
4
[In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
Jpn J Antibiot. 1975 Dec;28(6):785-94.
5
Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.新型头孢菌素头孢唑肟(FK 749)与其他头孢菌素类抗生素抗菌活性的比较。
J Antibiot (Tokyo). 1979 Dec;32(12):1319-27. doi: 10.7164/antibiotics.32.1319.
6
In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
Arzneimittelforschung. 1989 Jan;39(1):26-30.
7
Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.阿帕西林(PC - 904)对革兰氏阴性杆菌,尤其是对氨苄西林、羧苄西林和庆大霉素耐药的临床分离菌株的抗菌活性。
Antimicrob Agents Chemother. 1978 May;13(5):745-52. doi: 10.1128/AAC.13.5.745.
8
[Investigations on antibacterial activity of apalcillin].
Arzneimittelforschung. 1982;32(9):1128-30.
9
In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.新型半合成氨基糖苷类药物K-4619的体外和体内抗菌活性
Antimicrob Agents Chemother. 1984 Aug;26(2):187-91. doi: 10.1128/AAC.26.2.187.
10
Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.阿帕西林[PC-904]:抗菌谱及β-内酰胺酶的水解/抑制作用
Diagn Microbiol Infect Dis. 1985 Jan;3(1):7-17. doi: 10.1016/0732-8893(85)90061-6.

引用本文的文献

1
Pharmacokinetics of intravenous piperacillin administration in patients undergoing on-line hemodiafiltration.接受在线血液透析滤过治疗的患者静脉注射哌拉西林的药代动力学
Antimicrob Agents Chemother. 2009 Aug;53(8):3266-8. doi: 10.1128/AAC.01670-08. Epub 2009 May 18.
2
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.新型半合成头孢霉素抗生素T-1982的体外和体内抗菌活性
Antimicrob Agents Chemother. 1982 Nov;22(5):728-34. doi: 10.1128/AAC.22.5.728.
3
Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.阿洛西林和替卡西林对铜绿假单胞菌的杀菌效果比较
Antimicrob Agents Chemother. 1980 Jul;18(1):182-9. doi: 10.1128/AAC.18.1.182.
4
Penetration of piperacillin into bronchial mucosa and sputum.哌拉西林在支气管黏膜及痰液中的穿透性。
Thorax. 1981 Oct;36(10):774-80. doi: 10.1136/thx.36.10.774.
5
Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.哌拉西林的体外比较评估,包括其对伤寒沙门氏菌的活性。
Antimicrob Agents Chemother. 1980 Oct;18(4):493-501. doi: 10.1128/AAC.18.4.493.
6
Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.莫西拉坦(6059-S),一种新型的具有扩大抗菌谱的1-氧杂-β-内酰胺:实验室评估
Antimicrob Agents Chemother. 1980 Mar;17(3):302-12. doi: 10.1128/AAC.17.3.302.
7
Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.哌拉西林、替卡西林和羧苄西林药代动力学的比较研究。
Antimicrob Agents Chemother. 1980 Apr;17(4):608-11. doi: 10.1128/AAC.17.4.608.
8
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
9
Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.半合成青霉素与氨基糖苷类氨基环醇类药物对肠杆菌科细菌的早期协同相互作用。
Antimicrob Agents Chemother. 1983 Jun;23(6):902-6. doi: 10.1128/AAC.23.6.902.
10
The effect of piperacillin dose on elimination kinetics in renal impairment.
Eur J Clin Pharmacol. 1983;24(4):543-7. doi: 10.1007/BF00609901.

本文引用的文献

1
Iodometric assay of penicillinase.青霉素酶的碘量法测定
Nature. 1954 Nov 27;174(4439):1012-3. doi: 10.1038/1741012a0.
2
New semi-synthetic penicillin active against Pseudomonas pyocyanea.对绿脓杆菌有效的新型半合成青霉素。
Nature. 1967 Jul 1;215(5096):25-30. doi: 10.1038/215025a0.
3
Changing ecology of bacterial infections as related to antibacterial therapy.与抗菌治疗相关的细菌感染生态变化
J Infect Dis. 1970 Nov;122(5):419-31. doi: 10.1093/infdis/122.5.419.
4
Detection of a beta-lactamase markedly active against carbenicillin in a strain of Pseudomonas aeruginosa.在一株铜绿假单胞菌中检测到一种对羧苄青霉素具有显著活性的β-内酰胺酶。
J Bacteriol. 1970 Mar;101(3):1079-80. doi: 10.1128/jb.101.3.1079-1080.1970.
5
The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.大肠杆菌中由可传递R因子介导的青霉素β-内酰胺酶的纯化及特性
J Biochem. 1969 Jul;66(1):11-20. doi: 10.1093/oxfordjournals.jbchem.a129111.
6
Clinical pharmacology of ticarcillin (alpha-carboxyl-3-thienylmethyl penicillin, BRL-2288).替卡西林(α-羧基-3-噻吩甲基青霉素,BRL-2288)的临床药理学
Antimicrob Agents Chemother. 1973 Jul;4(1):31-6. doi: 10.1128/AAC.4.1.31.
7
Changing patterns in surgical infections.外科感染模式的变化
Ann Surg. 1973 Oct;178(4):436-45. doi: 10.1097/00000658-197310000-00006.
8
Semisynthetic -lactam antibiotics. 2. Synthesis and properties of D- and L- -sulfobenzylpenicillins.半合成β-内酰胺抗生素。2. D-和L-β-磺苄青霉素的合成与性质
J Med Chem. 1972 Nov;15(11):1108-11. doi: 10.1021/jm00281a005.
9
Biochemical properties of a cephalosporin beta-lactamase from Pseudomonas aeruginosa.铜绿假单胞菌头孢菌素β-内酰胺酶的生化特性
Jpn J Microbiol. 1973 Mar;17(2):141-9. doi: 10.1111/j.1348-0421.1973.tb00718.x.
10
Biochemical properties of a penicillin beta-lactamase mediated by R factor from Bordetella bronchiseptica.支气管败血波氏杆菌R因子介导的青霉素β-内酰胺酶的生化特性
Antimicrob Agents Chemother. 1975 Sep;8(3):238-42. doi: 10.1128/AAC.8.3.238.